Bill

Bill > HR4392


US HR4392

US HR4392
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025


summary

Introduced
07/15/2025
In Committee
07/15/2025
Crossed Over
Passed
Dead

Introduced Session

119th Congress

Bill Summary

A BILL To authorize the Secretary of Health and Human Services to award grants to increase early detection of and intervention for uterine fibroids, and for other purposes.

AI Summary

This bill aims to address uterine fibroid health by authorizing the Secretary of Health and Human Services (HHS) to conduct research and provide grants focused on early detection and intervention. The bill establishes a comprehensive approach that includes research, state-level grant programs, and reporting requirements. Specifically, the Secretary will conduct research to develop evidence-based strategies for early detection of uterine fibroids, and then offer grants to states to implement these strategies. States can use the grants for screening procedures, patient navigation services, implementing early detection strategies, and facilitating healthcare access. The bill prioritizes grants for geographic areas with socially vulnerable populations at higher risk of uterine fibroids. Additionally, the Secretary may award research grants to study pain management disparities in fibroid surgical treatment and other intrauterine conditions like Asherman's Syndrome. The bill requires biennial reports to Congress detailing the findings of grant-funded programs and research developments, which will be made publicly available. By focusing on research, education, and targeted interventions, the bill seeks to improve gynecological health outcomes, particularly for underserved populations.

Committee Categories

Business and Industry

Sponsors (55)

Shontel Brown (D)*,  Alma Adams (D),  Yassamin Ansari (D),  Troy Carter (D),  Yvette Clarke (D),  Angie Craig (D),  Debbie Dingell (D),  Cleo Fields (D),  Shomari Figures (D),  Lizzie Fletcher (D),  Valerie Foushee (D),  Al Green (D),  Jahana Hayes (D),  Pramila Jayapal (D),  Hank Johnson (D),  Sydney Kamlager-Dove (D),  Robin Kelly (D),  Ro Khanna (D),  Raja Krishnamoorthi (D),  George Latimer (D),  Summer Lee (D),  Seth Magaziner (D),  John Mannion (D),  Lucy McBath (D),  Sarah McBride (D),  April McClain-Delaney (D),  Jenn McClellan (D),  LaMonica McIver (D),  Rob Menendez (D),  Grace Meng (D),  Kweisi Mfume (D),  Ayanna Pressley (D),  Luz Rivas (D),  Andrea Salinas (D),  David Scott (D),  Terri Sewell (D),  Lateefah Simon (D),  Greg Stanton (D),  Haley Stevens (D),  Suhas Subramanyam (D),  Emilia Sykes (D),  Shri Thanedar (D),  Bennie Thompson (D),  Dina Titus (D),  Rashida Tlaib (D),  Jill Tokuda (D),  Ritchie Torres (D),  Lori Trahan (D),  Lauren Underwood (D),  Nydia Velázquez (D),  James Walkinshaw (D),  Debbie Wasserman Schultz (D),  Maxine Waters (D),  Bonnie Watson Coleman (D),  Frederica Wilson (D), 

Last Action

Referred to the House Committee on Energy and Commerce. (on 07/15/2025)

Bill Topics

Health
  • ‐ Disease Prevention
  • ‐ Research and Development
  • ‐ Treatment of Specific Diseases

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location Created
State Bill Page https://www.congress.gov/bill/119th-congress/house-bill/4392/all-info 07/16/2025
BillText https://www.congress.gov/119/bills/hr4392/BILLS-119hr4392ih.pdf 07/24/2025
Loading...